SARS-CoV-2 spike protein could be speeding up Alzheimer’s and other brain diseases, says new study

Swedish researchers find that SARS-CoV-2’s spike protein amyloids can accelerate the formation of harmful protein aggregates related to neurodegenerative diseases like Creutzfeldt-Jakob and Alzheimer’s. The study suggests a potential link between COVID-19 and increased cases of these brain disorders.

Slow Growth

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

Read More »